Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Acyclovir

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07721090Not ApplicableNot Yet Recruiting

Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model

NCT06380647Not ApplicableCompletedPrimary

Comparison of Prophylactic Acyclovir and Placebo in Prevention of Eczema Herpeticum in Pediatric Burns

Showing all 2 trials

Research Network

Common Treatments

  • Acyclovir1
  • Pharmacistled Prescribing Optimization And Patient Counselling1

Active Sponsors

  • Sri Balaji Vidyapeeth University1
  • University of Fujairah1
  • King Edward Medical University1

Top Investigators

Related Conditions

  • Recurrent Aphthous Stomatitis1
  • Burning Mouth Syndrome1
  • Oral Candidiasis1
  • Oral Lichen Planus1

Activity Timeline